Skip to main content
. 2020 Jul 17;2(5):100147. doi: 10.1016/j.jhepr.2020.100147

Fig. 3.

Fig. 3

Performance of the combination of LSN and LSPS for the diagnosis of CSPH.

(A) Performance in the intention-to-diagnose cohort and per-protocol cohort. (B) Performance of rule-in and rule-out cut-offs of non-invasive variables (LSN, LSM and LSPS) for predicting CSPH. CSPH, clinically significant portal hypertension; LSM, liver stiffness measurement; LSN, liver surface nodularity; LSPS, LSM-spleen-size-to-platelet ratio score.